Rankings
▼
Calendar
RCUS FY 2021 Earnings — Arcus Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RCUS
Arcus Biosciences, Inc.
$2B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$383M
+391.0% YoY
Gross Profit
$383M
100.0% margin
Operating Income
$54M
14.1% margin
Net Income
$53M
13.8% margin
EPS (Diluted)
$0.71
Cash Flow
Operating Cash Flow
-$256M
Free Cash Flow
-$282M
Stock-Based Comp.
$55M
Balance Sheet
Total Assets
$1.6B
Total Liabilities
$750M
Stockholders' Equity
$841M
Cash & Equivalents
$148M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$383M
$78M
+391.0%
Gross Profit
$383M
$78M
+391.0%
Operating Income
$54M
-$124M
+143.5%
Net Income
$53M
-$123M
+143.1%
← Q4 2020
All Quarters
Q1 2021 →